[Transitory (presystemic) forms of lupus erythematosus and characteristics of their immunotherapy].
The authors' findings confirm the possibility of such forms. In 16.5% of cases lupus erythematosus transforms from the discoid form and in 6.9% of cases from the disseminated form, immunologically presenting as T- or B-dependent lupus erythematosus. The authors describe immunocorrecting therapy for various forms of the disease, including immunosuppression of T- and B-lymphocytes by the quinoline series drugs or by their combinations with corticosteroids, as well as immunostimulation of T-lymphocytes by the imidazole series drugs or by thymus hormones.
Gorbunov
V F
VF
Shaposhnikov
O K
OK
Korol'kova
T N
TN
Mishina
O V
OV
D000293:Adolescent; D000328:Adult; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis* / Q000628:therapy; D008297:Male
Perekhodnye (predsistemnye) formy krasnoĭ volchanki i osobennosi ikh immunoterapii.